Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     

  • GBP/USD

    1.2491
    -0.0020 (-0.16%)
     

  • Bitcoin GBP

    51,217.28
    -733.26 (-1.41%)
     

  • CMC Crypto 200

    1,383.71
    -12.82 (-0.92%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     

  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Australia regulator approves Pfizer/BioNTech COVID-19 for use

Reuters
Updated ·1-min read

SYDNEY, Jan 25 (Reuters) - Australia's therapeutic goods regulator has conditionally approved the Pfizer/BioNTech COVID-19 vaccine for use after determining that it met strict standards for safety, quality and efficacy, the federal government said on Monday.

The Therapeutic Goods Administration's (TGA) provisional approval is for people aged over 16, and a priority group of Australians would receive their first of two doses of the vaccine once received from the drugmaker, the government added.

"I welcome the TGA's approval of the Pfizer vaccine, with our own Australian experts finding it is safe, effective and of a high standard," Prime Minister Scott Morrison said in a statement. (Reporting by Byron Kaye; editing by Diane Craft)